Citadel Advisors’s Marex Group Limited Ordinary Shares MRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
19,000
+11,500
+153% +$633K ﹤0.01% 7849
2026
Q1
$334K Sell
7,500
-1,400
-16% -$55.3K ﹤0.01% 10227
2025
Q4
$341K Sell
8,900
-2,000
-18% -$68K ﹤0.01% 9857
2025
Q3
$366K Sell
10,900
-3,900
-26% -$141K ﹤0.01% 9875
2025
Q2
$584K Buy
14,800
+10,500
+244% +$437K ﹤0.01% 8285
2025
Q1
$152K Sell
4,300
-3,300
-43% -$115K ﹤0.01% 10857
2024
Q4
$237K Buy
7,600
+4,100
+117% +$115K ﹤0.01% 10138
2024
Q3
$82.7K Buy
3,500
+3,200
+1,067% +$71.4K ﹤0.01% 11371
2024
Q2
$6K Buy
+300
New +$5.9K ﹤0.01% 13368

Other funds holding MRX

Citadel Advisors's MRX Position: Q2 2026 in Review

Citadel Advisors sold out of Marex Group Limited Ordinary Shares (MRX) in Q2 2026, closing a stake of 173,474 shares — an estimated $9.55M sold.

Citadel Advisors first reported a position in MRX in Q2 2024 and held it in 8 quarters. The position peaked at $38.7M in Q2 2025. 221 funds tracked by Wall St. Rank hold MRX as of Q2 2026.

  • Citadel Advisors reported no remaining Marex Group Limited Ordinary Shares position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 173,474 Marex Group Limited Ordinary Shares shares in Q2 2026, an estimated $9.55M.
  • Citadel Advisors first reported a position in Marex Group Limited Ordinary Shares in Q2 2024 and held it in 8 quarters.
  • Citadel Advisors's Marex Group Limited Ordinary Shares position peaked at $38.7M in Q2 2025.
  • 221 funds tracked by Wall St. Rank held Marex Group Limited Ordinary Shares as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.